This is part of the phase II dose-finding study design in order to understand the efficacy and safety of specific dosing regimens and titrations. No severe hypoglycaemic episodes were recorded
Across the treatment arms, the mean age of patients was 57 years, 3.2% were 75 years or older and 57% were male
Levocarnitine preserves lean mass during GLP-1-mediated weight loss
Chronic insomnia is linked to increased risks of depression, anxiety disorders, and diminished overall health, making its treatment a critical focus
If your BMI is less than 30 but is 27 or higher than you can still be eligible if you have another health condition that can impede your ability to lose weight, this can include conditions such as high blood pressure, high cholesterol or in some cases women with PCOS may also be eligible
Melanotan I Evidence at a Glance The strength of evidence varies considerably according to the proposed use